Jae‐Sung Lim

Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

James F. Howard, Kimiaki Utsugisawa, Michael Benatar et al. · The Lancet Neurology · 2017 · 800 citations

Medicine, Pharmacology, Pharmacotherapy +6

Strategic infarct locations for post-stroke cognitive impairment: a pooled analysis of individual patient data from 12 acute ischaemic stroke cohorts

Nick A. Weaver, Hugo J. Kuijf, Hugo P. Aben et al. · The Lancet Neurology · 2021 · 311 citations · Full text

Medicine, Neurology, Neuroscience +15

Profile of and risk factors for poststroke cognitive impairment in diverse ethnoregional groups

Jessica Lo, John D. Crawford, David W. Desmond et al. · Neurology · 2019 · 256 citations · Full text

Medicine, Neurology, Cognitive Neurology +16

High Triglyceride Glucose Index Is Associated with Poor Outcomes in Ischemic Stroke Patients after Reperfusion Therapy

Minwoo Lee, Chulho Kim, Yerim Kim et al. · Cerebrovascular Diseases · 2021 · 104 citations

Medicine, Neurology, Neurosurgery +17

Post-stroke cognitive impairment as an independent predictor of ischemic stroke recurrence: PICASSO sub-study

Hyuk Sung Kwon, Dongwhane Lee, Min Hwan Lee et al. · Journal of Neurology · 2019 · 99 citations

Medicine, Neurology, Neuroscience +15